New Immune Marker Research on Ketamine for Treatment-Resistant Depression (2026 Study)
IL-15 and IL-7: the immune markers a new 2026 study looked at beyond the standard inflammation markers (CRP and IL-6), and how they tracked with ketamine response in depression.
Research Review: Cannabidiol's Potential in Reversing Fentanyl Addiction and Reducing Neuroinflammation
Dr. Weiner reviews a recently published study on the potential of Cannabidiol (CBD) in treating fentanyl addiction. CBD's anti-inflammatory properties could revolutionize addiction therapy by providing a safe and effective treatment alternative that mitigates neuroinflammatory responses, offering hope in the battle against the opioid crisis.